Pharmaceutical containing TNF inhibitor

Details Pharmaceutical containing TNF inhibitor Pharmaceutical containing TNF inhibitor

1989-05-25

1992-06-02

Nucker, Christine

Drug, bio-affecting and body treating compositions

Lymphokine

514 21, 424 88, A61K 4505, A61K 3700, A61K 3900

Patent

active

051185008

ABSTRACT:
Pharmaceuticals which contain a substance releasing tumor necrosis factor (TNF) are better tolerated and can be given in higher doses when they contain a TNF inhibitor, especially a xanthine derivative.

REFERENCES:
patent: 4879111 (1989-11-01), Chong
C. M. Lilly et al., American Review of Respiratory Disease, vol. 137, No. 4, Part 2, Apr. 1988, p. 138, New York, US.
R. M. Strieter et al., Biochemical and Biophysical Research Communications, vol. 155, No. 3, Sep. 1988, pp. 1230-1236. New York, US.
Clinical Hemorheology, vol. 6, pp. 455-467 (1986).
Drugs of the Future, vol. 12, pp. 891-898 (1987).
Nature, vol. 330, pp. 662-664 (1987).

Affiliated with

Also associated with

Rating

Pharmaceutical containing TNF inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical containing TNF inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical containing TNF inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2227223